ZA982403B - Detection of endometrial cancer - Google Patents

Detection of endometrial cancer

Info

Publication number
ZA982403B
ZA982403B ZA982403A ZA982403A ZA982403B ZA 982403 B ZA982403 B ZA 982403B ZA 982403 A ZA982403 A ZA 982403A ZA 982403 A ZA982403 A ZA 982403A ZA 982403 B ZA982403 B ZA 982403B
Authority
ZA
South Africa
Prior art keywords
endometrial cancer
detection
matrix metalloproteinase
assaying
qualitative
Prior art date
Application number
ZA982403A
Other languages
English (en)
Inventor
Alexander Lopata
Lois A Salamonsen
Michael A Quinn
Original Assignee
Univ Melbourne
Prince Henrys Inst Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Melbourne, Prince Henrys Inst Med Res filed Critical Univ Melbourne
Publication of ZA982403B publication Critical patent/ZA982403B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA982403A 1997-03-20 1998-03-20 Detection of endometrial cancer ZA982403B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO5736A AUPO573697A0 (en) 1997-03-20 1997-03-20 Diagnosis of endometrial cancer

Publications (1)

Publication Number Publication Date
ZA982403B true ZA982403B (en) 1998-10-21

Family

ID=3800039

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982403A ZA982403B (en) 1997-03-20 1998-03-20 Detection of endometrial cancer

Country Status (14)

Country Link
US (1) US6607894B1 (cg-RX-API-DMAC10.html)
EP (1) EP0979304B1 (cg-RX-API-DMAC10.html)
JP (2) JP4183757B2 (cg-RX-API-DMAC10.html)
KR (1) KR20010006344A (cg-RX-API-DMAC10.html)
CN (1) CN1257550A (cg-RX-API-DMAC10.html)
AT (1) ATE331039T1 (cg-RX-API-DMAC10.html)
AU (1) AUPO573697A0 (cg-RX-API-DMAC10.html)
CA (1) CA2284099C (cg-RX-API-DMAC10.html)
DE (1) DE69835010T2 (cg-RX-API-DMAC10.html)
ES (1) ES2268767T3 (cg-RX-API-DMAC10.html)
MY (1) MY119567A (cg-RX-API-DMAC10.html)
NZ (1) NZ337868A (cg-RX-API-DMAC10.html)
WO (1) WO1998042865A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA982403B (cg-RX-API-DMAC10.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045147A1 (en) * 1998-03-05 1999-09-10 Diadexus Llc A novel method of detecting and monitoring endometrial and uterine cancers
AUPQ219799A0 (en) 1999-08-13 1999-09-02 R. Lurie Pty Ltd Apparatus for obtaining potological samples
US7094754B2 (en) 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
DE10217677A1 (de) 2002-04-19 2003-11-06 Bayer Ag Verwendung von Aufhellern zur Herstellung von Streichmassen
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
EP1782068B1 (en) * 2004-07-23 2010-04-07 Centre de Recherche Public de la Santé Monitoring heart failure
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
WO2006086730A2 (en) * 2005-02-09 2006-08-17 Genentech, Inc. Inhibiting her2 shedding with matrix metalloprotease antagonists
US7504225B2 (en) * 2005-05-12 2009-03-17 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
RU2304782C1 (ru) * 2005-12-28 2007-08-20 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Способ прогнозирования рецидива эндометриоидной кисты яичника
EP2205642B1 (en) 2007-11-02 2016-01-27 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
DK2419736T3 (da) * 2009-04-16 2014-04-22 Momenta Pharmaceuticals Inc Fremgangsmåder til vurdering af aktivitet af en polysaccharidsammensætning
CN105132529A (zh) * 2009-07-24 2015-12-09 吉第克生物技术有限公司 子宫内膜癌的标记物
BR112012026542A2 (pt) 2010-04-16 2016-07-12 Momenta Pharmaceuticals Inc abordagem seletiva de tecido
RU2430371C1 (ru) * 2010-04-26 2011-09-27 Учреждение Российской академии наук Институт ядерной физики им. Г.И. Будкера Сибирского отделения РАН (ИЯФ СО РАН) Способ дифференциальной диагностики и прогноза миомы и рака эндометрия
AU2011268470B2 (en) 2010-06-17 2017-02-02 Momenta Pharmaceuticals, Inc. Methods and compositions for promoting hair growth
CA2838053A1 (en) * 2011-06-03 2012-12-06 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
CN107389936A (zh) * 2011-09-22 2017-11-24 斯隆-凯特林纪念癌症中心 检测卵巢癌
HRP20181726T1 (hr) * 2012-01-31 2018-12-28 SPEISER, Paul Neinvazivno dijagnosticiranje raka
US10016449B2 (en) 2013-05-28 2018-07-10 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
AU2015283811A1 (en) * 2014-07-02 2017-02-09 Bionomics Limited Predictive biomarkers
CA2975737A1 (en) * 2015-02-06 2016-08-11 Quest Diagnostics Investments Llc Compositions and methods for determining endometrial cancer prognosis
PT3452829T (pt) * 2016-05-04 2024-03-22 Fundacio Hospital Univ Vall Dhebron Institut De Recerca Perm como marcador de cancro endometrial
IN202021002695A (cg-RX-API-DMAC10.html) 2020-01-21 2021-07-23
CN112961921B (zh) * 2021-03-26 2022-07-01 中国医学科学院北京协和医院 一种用于判断早期子宫内膜癌预后的制剂及复发风险模型

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
WO1994005807A1 (en) * 1992-08-28 1994-03-17 Dickson Robert B Matrix-degrading metalloproteinase
JPH09503901A (ja) * 1992-11-16 1997-04-22 キャンサー リサーチ ファンド オブ コントラ コスタ 広範な新生物特異性を有するペプチドおよびアンチセンスペプチド

Also Published As

Publication number Publication date
MY119567A (en) 2005-06-30
WO1998042865A1 (en) 1998-10-01
EP0979304A4 (en) 2003-06-11
ES2268767T3 (es) 2007-03-16
AUPO573697A0 (en) 1997-04-10
DE69835010D1 (de) 2006-08-03
EP0979304B1 (en) 2006-06-21
JP2002501613A (ja) 2002-01-15
JP4183757B2 (ja) 2008-11-19
ATE331039T1 (de) 2006-07-15
DE69835010T2 (de) 2007-06-06
US6607894B1 (en) 2003-08-19
NZ337868A (en) 2002-05-31
CN1257550A (zh) 2000-06-21
CA2284099A1 (en) 1998-10-01
KR20010006344A (ko) 2001-01-26
EP0979304A1 (en) 2000-02-16
JP2007202556A (ja) 2007-08-16
CA2284099C (en) 2010-04-27

Similar Documents

Publication Publication Date Title
AUPO573697A0 (en) Diagnosis of endometrial cancer
AU4157696A (en) Quantitative method for early detection of mutant alleles and diagnostic kits for carrying out the method
IL143892A0 (en) Kidney disease detection and treatment
WO2000023614A8 (en) Method for monitoring proteasome inhibitor drug action
FI953445A0 (fi) Menetelmä nukleiinihappojen herkkään osoitukseen
IL109817A0 (en) Improved method and analytical system for performing fibrinogen assays accurately, rapidly and simply
AU5212199A (en) Methods and kits for diagnosing and determination of the predisposition of diseases
AU1671300A (en) Cancer detection method and reagents
DE69931910D1 (en) Pränatales screening für downs-syndrom
GB9621129D0 (en) Detecting genetic predisposition to sight-threatening diabetic retinopathy
MX9300495A (es) Metodo rapido y cuantitativo, altamente sensible para detectar y cuantificar el arn mensajero en una muestra.
GB2335769A (en) Method and apparatus for performing TLB shootdown operations in a multiprocessor system
DE3750093D1 (de) Test zur Feststellung der Empfänglichkeit für DNS-assoziierte Krankheiten.
IL81695A (en) Quantitative determination of the degree of amplification of genes and/or corresponding messenger rna and reagent kit for performing the determination
CA2269664A1 (en) Diagnostic assay for breast cancer susceptibility
DE3264721D1 (en) Reagent for assaying hydrogen peroxide and method of quantitative assay for hydrogen peroxide
EP0657547A4 (en) METHOD FOR MEASURING ANTITHROMBIN III ACTIVITY AND REAGENT FOR THIS METHOD.
GB9604305D0 (en) Diagnostic method and apparatus
EP1141703A4 (en) METHODS FOR DETERMINING INCREASED RISK FOR A WOMAN CARRYING A FETUS WITH DOWN SYNDROME
AU2904197A (en) Diagnostic method and apparatus based on polymorphism in an IL-6 gene
MX9600860A (es) Metodo para detectar polimorfismo de gen p4501a2 de citocromo humano.
CA2328955A1 (en) Fetal testing for prediction of low birth weight
EP0158224A3 (en) Analysis method and means for detecting esterolytic and/or proteolytic enzymes
CY2403B1 (en) Determination of analytes by means of two markers.
DE3572511D1 (en) Analysis method and means for detecting esterolytic and or proteolytic enzymes